ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,331Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 783

$768K Total Retail Price of All Prescriptions

Rank: 110 out of 783

567 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 567 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 16,031 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 779 740 1 3
FUROSEMIDE 578 545 2 7
HYDROCODONE-ACETAMINOPHEN 547 494 S3 3 2
AMLODIPINE BESYLATE 526 499 4 5
LEVOTHYROXINE SODIUM 506 479 5 1
OMEPRAZOLE 499 481 6 6
LISINOPRIL 441 422 7 4
WARFARIN SODIUM 372 301 8 10
METOPROLOL TARTRATE 361 317 9 9
GABAPENTIN 360 320 10 15
RANITIDINE HCL 328 304 11 44
ATENOLOL 319 308 12 17
DONEPEZIL HCL 311 307 13 24
CITALOPRAM HBR 303 288 14 19
POTASSIUM CHLORIDE 296 270 15 16
METFORMIN HCL 292 274 16 8
TAMSULOSIN HCL 291 270 17 26
METOPROLOL SUCCINATE 263 258 18 13
ZOLPIDEM TARTRATE 201 174 19 23
ATORVASTATIN CALCIUM 182 171 20 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 181 181 21 33
AZITHROMYCIN 172 165 22 41
NAMENDA 169 168 23 32
LANTUS 162 127 24 38
LOSARTAN POTASSIUM 160 155 25 18
CLOPIDOGREL 152 142 26 29
TRIAMTERENE-HCTZ 149 148 27 42
MELOXICAM 148 139 28 37
POLYETHYLENE GLYCOL 3350 141 122 29 43
PAROXETINE HCL 140 127 30 69
TRAMADOL HCL 139 136 31 20
PRAVASTATIN SODIUM 130 116 32 14
GLIPIZIDE 125 107 33 71
HYDROCHLOROTHIAZIDE 125 117 33 12
ALENDRONATE SODIUM 122 118 35 25
CARVEDILOL 120 101 36 21
PREDNISONE 115 101 37 36
ISOSORBIDE MONONITRATE ER 115 115 37 40
TRAZODONE HCL 114 100 39 39
CYMBALTA 110 96 40 35
LOSARTAN-HYDROCHLOROTHIAZIDE 106 106 41 53
DIVALPROEX SODIUM 96 80 42 72
BISOPROLOL-HYDROCHLOROTHIAZIDE 95 95 43 154
ESCITALOPRAM OXALATE 92 78 44 54
HUMALOG 90 71 45 101
HYDRALAZINE HCL 88 88 46 78
RISPERIDONE 85 85 47 67
EXELON 85 85 47 109
FAMOTIDINE 83 78 49 55
GLIPIZIDE ER 83 76 49 84
CIPROFLOXACIN HCL 81 77 51 62
FENTANYL 79 58 S2 52 65
DIOVAN 79 79 52 49
ALLOPURINOL 75 71 54 31
SERTRALINE HCL 73 72 55 22
BISOPROLOL FUMARATE 72 72 56 202
MIRTAZAPINE 70 70 57 52
CLOTRIMAZOLE-BETAMETHASONE 70 58 57 189
PLAVIX 70 70 57 51
IPRATROPIUM-ALBUTEROL 67 66 60 110
METOCLOPRAMIDE HCL 65 61 61 121
DIOVAN HCT 64 61 62 94
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 56 63 95
AMOX TR-POTASSIUM CLAVULANATE 61 54 64 128
AMOXICILLIN 61 51 64 116
OXYCODONE-ACETAMINOPHEN 58 46 S2 66 76
NIFEDIPINE ER 57 50 67 135
PROMETHAZINE HCL 56 48 R 68 97
EVISTA 56 56 68 92
DILTIAZEM ER 54 53 70 153
DIGOXIN 54 53 70 61
KLOR-CON M20 54 50 70 48
GEMFIBROZIL 53 53 73 105
SPIRONOLACTONE 52 51 74 57
FLUOXETINE HCL 51 44 75 45
METFORMIN HCL ER 50 50 76 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.